COST-UTILITY AND BUDGET IMPACT ANALYSES OF TUMOR NECROSIS FACTOR INHIBITOR BIOLOGICS AND BIOSIMILARS VERSUS RITUXIMAB IN THAI PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

被引:0
|
作者
Leelahavarong, P. [1 ]
Osiri, M. [2 ]
Koolvisoot, A. [3 ]
Prawjaeng, J. [4 ]
Budtarad, N. [1 ]
机构
[1] Mahidol Univ, Siriraj Hosp, Fac Med, Siriraj Hlth Policy Unit, Bangkok, Thailand
[2] Chulalongkorn Univ, Div Rheumatol, Dept Med, Fac Med, Pathumwan, Thailand
[3] Mahidol Univ, Siriraj Hosp, Fac Med, Div Rheumatol, Bangkok, Thailand
[4] Mahidol Univ, Fac Med, Siriraj Hlth Policy Unit, Siriraj Hosp, Bangkok, Thailand
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE424
引用
收藏
页码:S132 / S133
页数:2
相关论文
共 50 条
  • [31] Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis
    Bruna de Oliveira Ascef
    Matheus Oliveira Almeida
    Ana Cristina de Medeiros-Ribeiro
    Danieli Castro de Oliveira Andrade
    Haliton Alves de Oliveira Junior
    Patrícia Coelho de Soárez
    Scientific Reports, 13
  • [32] Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients' Burden of Disease
    Moghadam, Marjan Ghiti
    ten Klooster, Peter M.
    Vonkeman, Harald E.
    Kneepkens, Eva L.
    Klaasen, Ruth
    Stolk, Jan N.
    Tchetverikov, Ilja
    Vreugdenhil, Simone A.
    van Woerkom, Jan M.
    Goekoop-Ruiterman, Yvonne P. M.
    Landewe, Robert B. M.
    van Riel, Piet L. C. M.
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (04) : 516 - 524
  • [33] Impact of Tumor Necrosis Factor Inhibition on Healthcare Costs in Patients with Rheumatoid Arthritis.
    Maksymowych, Walter P.
    Nguen Xuan Thanh
    Homik, Joanne
    Barnabe, Cheryl C. M.
    Martin, Liam
    Barr, Susan G.
    Ohinmaa, Arto
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S171 - S171
  • [34] Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis
    Ascef, Bruna de Oliveira
    Almeida, Matheus Oliveira
    de Medeiros-Ribeiro, Ana Cristina
    Andrade, Danieli Castro de Oliveira
    de Oliveira Junior, Haliton Alves
    de Soarez, Patricia Coelho
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [35] Changes in Bone Metabolism in Patients with Rheumatoid Arthritis during Tumor Necrosis Factor Inhibitor Therapy
    Jankovic, Tanja
    Mikov, Momir
    Zvekic Svorcan, Jelena
    Minakovic, Ivana
    Mikov, Jelena
    Boskovic, Ksenija
    Mikic, Darko
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [36] Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis
    Park, Siyeon
    Le, Tham T.
    Slejko, Julia F.
    Villalonga-Olives, Ester
    Onukwugha, Eberechukwu
    RHEUMATOLOGY AND THERAPY, 2019, 6 (04) : 611 - 616
  • [37] Tumor Necrosis Factor- Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis
    Desai, Rishi J.
    Solomon, Daniel H.
    Schneeweiss, Sebastian
    Danaei, Goodarz
    Liao, Katherine P.
    Kim, Seoyoung C.
    EPIDEMIOLOGY, 2016, 27 (03) : 414 - 422
  • [38] Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis
    Low, Audrey S. L.
    Lunt, Mark
    Mercer, Louise K.
    Watson, Kath D.
    Dixon, William G.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (06) : 1337 - 1345
  • [39] Perioperative Management of Methotrexate and Tumor Necrosis Factor Inhibitor Combination Therapy in Rheumatoid Arthritis Patients
    Juo, Hsin-Hsuan
    Ng, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [40] The Prevalence of Loss of Response to Treatment with a Tumor Necrosis Factor Inhibitor and/or Methotrexate in Patients with Rheumatoid Arthritis
    Smolen, Josef
    Li, Yihan
    Sainsbury, Iain
    Florentinus, Stefan
    Rambalee, Kershnie
    Burmester, G. R.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68